|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Division of Thoracic Surgery, Rush University Medical Center, Suite 774, 1725 W Harrison St, Chicago, IL 60612-3824
(Email: michael_liptay@rush.edu).
| The first 20% of the full text of this article appears below. |
Malignant pleural mesothelioma is an aggressive diffuse spreading tumor that has a generally poor outlook with mean survivals of less than 2 years regardless of treatment approach. These authors [1] examined the pattern of lymph node metastases in their series from the National Cancer Institute of Cairo, Egypt.
Lymph node metastases were originally shown to be a bad prognostic factor in mesothelioma by Sugarbaker and
Related Article
Ann. Thorac. Surg. 2008 86: 391-395.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |